Listed by the USPTO as SHIAO, REI TSANG
Tech Center 1600 • Art Units: 1614 1626 1628 1629 1642 1691
This examiner grants 80% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18849133 | THERAPEUTIC OR PROPHYLACTIC MEDICINE FOR FRAGILE X SYNDROME | Non-Final OA | Kyoto University |
| 18864465 | USE OF A POLYCARBOXYLATE COPOLYMER AND ALKYL ETHER SULFATE AS COMPATIBILIZER IN TANK MIX COMPOSITION | Non-Final OA | SPECIALTY OPERATIONS FRANCE |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy79.9% of resolved applications examined by Rei Tsang Shiao were allowed (2,073 resolved cases), compared with 47.9% across Art Unit 1614 over the last five years.
This examiner's interview lift is -33.5 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Rei Tsang Shiao took 761 days on average from filing to allowance.
Rei Tsang Shiao examines applications in Art Unit 1614 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
